Get started
Author

Robin Noël

Observed names: NOEL, Robin, Noel Robin, Noel, Robin, Noël, Robin, R. Noel, R. Noël, Robin Noel
Observed institutions: Lyon 1 Université, Aix-Marseille Université, Hospices Civils de Lyon, CHU Dijon Bourgogne, Centre de Recherche en Cancérologie de Marseille, Actalia (France), Institut Paoli-Calmettes, Centre Hospitalier William Morey
ORCID: 0000-0002-7048-5491
Observed ORCID: 0000-0002-7048-5491
OpenAlex ID: A5063068054
Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient
2012 · Sébastien Gibot, Marie C. Béné, et al. · American Journal of Respiratory and Critical Care Medicine · 299
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
2025 · Arthur Géraud, Paul Gougis, et al. · Cancer Treatment Reviews · 31
Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis
2016 · P. E. Charles, R. Noel, et al. · BMC Infectious Diseases · 31
PDF
Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines
2024 · Cédric Rossi, Guillaume Manson, et al. · European Journal of Cancer · 28
PDF
Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations
2014 · Nadiejda Antier, Jean-Pierre Quenot, et al. · Annals of Intensive Care · 19
PDF
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines
2025 · Loïc Renaud, Marie Donzel, et al. · European Journal of Cancer · 18
PDF
Large B-cell lymphoma: The LYSA pragmatic guidelines
2025 · Pierre Sesques, Guillaume Manson, et al. · European Journal of Cancer · 7
PDF
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma
2025 · Vincent Camus, Thierry Molina, et al. · Blood Advances · 7
PDF
Autologous Stem Cell Transplant in 2nd Line DLBCL in 2022, Still the Standard of Care ? a Monocentric Experience
2022 · Aude Collignon, Benjamin Bouchacourt, et al. · Blood · 6
Plamotamab: First Presentation of Subcutaneous Administration in a Phase 1 Dose Escalation Study in Heavily Pretreated R/R NHL Patients Who Had Prior CAR-T Cell Therapy
2024 · Peter A. Riedell, Krish Patel, et al. · Blood · 5
PDF
Diffuse Subcutaneous Fat Involvement in a Marginal Zone Lymphoma
2016 · Julien Dubreuil, Robin Noel, et al. · Clinical Nuclear Medicine · 5
Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience
2025 · Robin Noel, Catalina Montes de Oca, et al. · Hematological Oncology · 4
PDF
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma
2023 · Robin Noel, Christophe Zemmour, et al. · Hematology · 3
PDF
Isolated hepatosplenic sarcoidosis: A pitfall for lymphoma evaluation by 18 F-FDG PET/CT
2017 · J. Dubreuil, J. Leenhardt, et al. · Revista Española de Medicina Nuclear e Imagen Molecular · 3
Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience
2026 · Gaetan Basile, Arnaud Neuville, et al. · Haematologica · 2
PDF
Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa
2024 · Vincent Camus, Thierry Jo Molina, et al. · Blood · 2
PDF
Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study
2022 · Pauline Roché, Gabriel Brisou, et al. · Blood · 2
Monomorphic Epitheliotropic Intestinal T‐cell Lymphoma (meitl): Clinico‐pathological Analysis of a Multicenter European Cohort
2021 · D. Cavalieri, O. Tournilhac, et al. · Hematological Oncology · 2
PDF
Somatic Mutation Profile Analyzed By Next-Generation Sequencing in Relapsed/Refractory Follicular Lymphoma Treated with Idelalisib
2019 · Philippine Robert, Cédric Rossi, et al. · Blood · 2
Efficacy and safety of steroid‐sparing strategy in the treatment of AIHA associated with KSHV/HHV‐8 positive multicentric Castleman disease
2026 · Yannick Dieudonné, Clément Gourguechon, et al. · HemaSphere · 1
Preliminary data on epcoritamab and glofitamab as bridging therapy prior to CAR T-cell treatment in Relapsed/Refractory large B cell lymphoma
2025 · Pauline PIAZZOLA, Anne CALLEJA, et al. · Blood · 1
Pd‐1 Blockade in a French Series of 13 Relapsed / Refractory Nk/t‐cell Lymphoma Patients
2019 · L. Couronné, S. Chaubard, et al. · Hematological Oncology · 1
PDF
Exploring liverSUVmax% as a practical alternative to ΔSUVmax for interim PET/CT assessment in DLBCL: a validation cohort study and a single-centre retrospective exploratory analysis
2026 · Guillemette Gagey, Julia Gilhodes, et al. · Frontiers in Medicine
PDF
Datasets LOT 2 INCYVIE_Fichiers ELDA.zip
2026 · Emonet Emeric, Audoye Pauline, et al. · Recherche Data Gouv France
Protocole pour les Grandes Cultures
2026 · Emonet Emeric, Audoye Pauline, et al. · Recherche Data Gouv France
Works count: 63
Citation count: 479
H-index: 7
I10-index: 6
Year
Topic
Type